nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—Tolbutamide—type 2 diabetes mellitus	0.192	0.522	CrCtD
Probenecid—Chlorpropamide—type 2 diabetes mellitus	0.175	0.478	CrCtD
Probenecid—ABCC2—type 2 diabetes mellitus	0.0519	0.547	CbGaD
Probenecid—SLC2A9—Losartan—type 2 diabetes mellitus	0.0389	0.184	CbGbCtD
Probenecid—SLC22A12—Losartan—type 2 diabetes mellitus	0.0281	0.133	CbGbCtD
Probenecid—CYP3A4—type 2 diabetes mellitus	0.0229	0.242	CbGaD
Probenecid—Tolbutamide—Glimepiride—type 2 diabetes mellitus	0.0224	0.0927	CrCrCtD
Probenecid—Tolbutamide—Tolazamide—type 2 diabetes mellitus	0.0224	0.0927	CrCrCtD
Probenecid—Tolbutamide—Gliclazide—type 2 diabetes mellitus	0.0212	0.0879	CrCrCtD
Probenecid—Tolbutamide—Glipizide—type 2 diabetes mellitus	0.0212	0.0879	CrCrCtD
Probenecid—ALB—type 2 diabetes mellitus	0.02	0.211	CbGaD
Probenecid—Tolbutamide—Chlorpropamide—type 2 diabetes mellitus	0.0194	0.0804	CrCrCtD
Probenecid—Chlorpropamide—Glimepiride—type 2 diabetes mellitus	0.0187	0.0775	CrCrCtD
Probenecid—Chlorpropamide—Tolazamide—type 2 diabetes mellitus	0.0187	0.0775	CrCrCtD
Probenecid—Chlorpropamide—Gliclazide—type 2 diabetes mellitus	0.0178	0.0735	CrCrCtD
Probenecid—Chlorpropamide—Glipizide—type 2 diabetes mellitus	0.0178	0.0735	CrCrCtD
Probenecid—Chlorpropamide—Tolbutamide—type 2 diabetes mellitus	0.0178	0.0735	CrCrCtD
Probenecid—SLC16A1—Nateglinide—type 2 diabetes mellitus	0.0133	0.0628	CbGbCtD
Probenecid—Chlorpropamide—Glyburide—type 2 diabetes mellitus	0.0123	0.0509	CrCrCtD
Probenecid—Sulfacetamide—Tolazamide—type 2 diabetes mellitus	0.00847	0.035	CrCrCtD
Probenecid—Sulfacetamide—Tolbutamide—type 2 diabetes mellitus	0.00803	0.0332	CrCrCtD
Probenecid—Sulfacetamide—Gliclazide—type 2 diabetes mellitus	0.00803	0.0332	CrCrCtD
Probenecid—Sulfacetamide—Chlorpropamide—type 2 diabetes mellitus	0.00734	0.0304	CrCrCtD
Probenecid—ABCC4—Nateglinide—type 2 diabetes mellitus	0.00638	0.0302	CbGbCtD
Probenecid—ABCC3—Glyburide—type 2 diabetes mellitus	0.00564	0.0267	CbGbCtD
Probenecid—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.00538	0.0255	CbGbCtD
Probenecid—SLC22A7—Glyburide—type 2 diabetes mellitus	0.00441	0.0209	CbGbCtD
Probenecid—ALB—Gliclazide—type 2 diabetes mellitus	0.00367	0.0174	CbGbCtD
Probenecid—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.00366	0.0173	CbGbCtD
Probenecid—ABCC1—Glyburide—type 2 diabetes mellitus	0.00346	0.0164	CbGbCtD
Probenecid—ALB—Repaglinide—type 2 diabetes mellitus	0.00345	0.0163	CbGbCtD
Probenecid—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00334	0.0158	CbGbCtD
Probenecid—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.00327	0.0155	CbGbCtD
Probenecid—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.00309	0.0146	CbGbCtD
Probenecid—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00288	0.0136	CbGbCtD
Probenecid—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.00278	0.0131	CbGbCtD
Probenecid—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00267	0.0126	CbGbCtD
Probenecid—ABCC2—Glyburide—type 2 diabetes mellitus	0.00256	0.0121	CbGbCtD
Probenecid—ALB—Valsartan—type 2 diabetes mellitus	0.00254	0.012	CbGbCtD
Probenecid—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00253	0.012	CbGbCtD
Probenecid—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00241	0.0114	CbGbCtD
Probenecid—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00238	0.0113	CbGbCtD
Probenecid—ALB—Nateglinide—type 2 diabetes mellitus	0.00237	0.0112	CbGbCtD
Probenecid—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00233	0.011	CbGbCtD
Probenecid—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00226	0.0107	CbGbCtD
Probenecid—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00223	0.0105	CbGbCtD
Probenecid—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00215	0.0102	CbGbCtD
Probenecid—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00213	0.0101	CbGbCtD
Probenecid—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00202	0.00958	CbGbCtD
Probenecid—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00202	0.00958	CbGbCtD
Probenecid—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00198	0.00936	CbGbCtD
Probenecid—SLC22A2—Metformin—type 2 diabetes mellitus	0.0019	0.009	CbGbCtD
Probenecid—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00188	0.00888	CbGbCtD
Probenecid—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00187	0.00884	CbGbCtD
Probenecid—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0018	0.00853	CbGbCtD
Probenecid—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00175	0.00829	CbGbCtD
Probenecid—SLC22A6—Losartan—type 2 diabetes mellitus	0.00172	0.00812	CbGbCtD
Probenecid—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00168	0.00796	CbGbCtD
Probenecid—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00168	0.00796	CbGbCtD
Probenecid—SLC22A1—Metformin—type 2 diabetes mellitus	0.00165	0.00782	CbGbCtD
Probenecid—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00163	0.00773	CbGbCtD
Probenecid—ALB—Glyburide—type 2 diabetes mellitus	0.0016	0.00756	CbGbCtD
Probenecid—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00155	0.00735	CbGbCtD
Probenecid—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00152	0.00718	CbGbCtD
Probenecid—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0015	0.0071	CbGbCtD
Probenecid—ALB—Losartan—type 2 diabetes mellitus	0.00146	0.00692	CbGbCtD
Probenecid—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00137	0.00649	CbGbCtD
Probenecid—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00135	0.0064	CbGbCtD
Probenecid—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00127	0.00603	CbGbCtD
Probenecid—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00124	0.00586	CbGbCtD
Probenecid—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00122	0.00578	CbGbCtD
Probenecid—CYP2C8—Losartan—type 2 diabetes mellitus	0.00113	0.00534	CbGbCtD
Probenecid—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00112	0.00531	CbGbCtD
Probenecid—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00108	0.00512	CbGbCtD
Probenecid—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00104	0.0049	CbGbCtD
Probenecid—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.000978	0.00463	CbGbCtD
Probenecid—CYP2C19—Losartan—type 2 diabetes mellitus	0.000947	0.00448	CbGbCtD
Probenecid—CYP2C9—Glyburide—type 2 diabetes mellitus	0.000861	0.00408	CbGbCtD
Probenecid—ABCB1—Glyburide—type 2 diabetes mellitus	0.000836	0.00396	CbGbCtD
Probenecid—CYP2C9—Losartan—type 2 diabetes mellitus	0.000788	0.00373	CbGbCtD
Probenecid—ABCB1—Losartan—type 2 diabetes mellitus	0.000764	0.00362	CbGbCtD
Probenecid—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.000741	0.00351	CbGbCtD
Probenecid—SLC22A10—liver—type 2 diabetes mellitus	0.000716	0.0456	CbGeAlD
Probenecid—CYP3A4—Orlistat—type 2 diabetes mellitus	0.000711	0.00336	CbGbCtD
Probenecid—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.000711	0.00336	CbGbCtD
Probenecid—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.000672	0.00318	CbGbCtD
Probenecid—SLC22A12—nephron tubule—type 2 diabetes mellitus	0.00063	0.0401	CbGeAlD
Probenecid—PANX1—islet of Langerhans—type 2 diabetes mellitus	0.000593	0.0377	CbGeAlD
Probenecid—SLC22A12—kidney—type 2 diabetes mellitus	0.000553	0.0352	CbGeAlD
Probenecid—SLC22A12—cortex of kidney—type 2 diabetes mellitus	0.000539	0.0343	CbGeAlD
Probenecid—CYP3A4—Glyburide—type 2 diabetes mellitus	0.000501	0.00237	CbGbCtD
Probenecid—CYP3A4—Losartan—type 2 diabetes mellitus	0.000458	0.00217	CbGbCtD
Probenecid—SLC2A9—nephron tubule—type 2 diabetes mellitus	0.000433	0.0275	CbGeAlD
Probenecid—PANX1—cardiovascular system—type 2 diabetes mellitus	0.000429	0.0273	CbGeAlD
Probenecid—SLC2A9—kidney—type 2 diabetes mellitus	0.00038	0.0242	CbGeAlD
Probenecid—PANX1—adipose tissue—type 2 diabetes mellitus	0.000378	0.0241	CbGeAlD
Probenecid—SLC2A9—cortex of kidney—type 2 diabetes mellitus	0.00037	0.0236	CbGeAlD
Probenecid—Chlorpropamide—ABCC8—type 2 diabetes mellitus	0.000294	0.249	CrCbGaD
Probenecid—Aplastic anaemia—Glyburide—type 2 diabetes mellitus	0.000287	0.0088	CcSEcCtD
Probenecid—Tolbutamide—ABCC8—type 2 diabetes mellitus	0.000287	0.242	CrCbGaD
Probenecid—Erythema multiforme—Chlorpropamide—type 2 diabetes mellitus	0.000284	0.00871	CcSEcCtD
Probenecid—ABCC6—retina—type 2 diabetes mellitus	0.000279	0.0178	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Repaglinide—type 2 diabetes mellitus	0.000266	0.00816	CcSEcCtD
Probenecid—PANX1—liver—type 2 diabetes mellitus	0.000265	0.0169	CbGeAlD
Probenecid—Erythema multiforme—Nateglinide—type 2 diabetes mellitus	0.000263	0.00807	CcSEcCtD
Probenecid—Leukopenia—Tolbutamide—type 2 diabetes mellitus	0.000258	0.00789	CcSEcCtD
Probenecid—SLC16A7—nephron tubule—type 2 diabetes mellitus	0.000255	0.0162	CbGeAlD
Probenecid—ABCC11—liver—type 2 diabetes mellitus	0.000254	0.0162	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Rosiglitazone—type 2 diabetes mellitus	0.000252	0.00771	CcSEcCtD
Probenecid—Haemolytic anaemia—Glyburide—type 2 diabetes mellitus	0.000246	0.00753	CcSEcCtD
Probenecid—SLC2A9—liver—type 2 diabetes mellitus	0.00024	0.0153	CbGeAlD
Probenecid—ABCC6—cardiovascular system—type 2 diabetes mellitus	0.000236	0.015	CbGeAlD
Probenecid—Leukopenia—Chlorpropamide—type 2 diabetes mellitus	0.000234	0.00718	CcSEcCtD
Probenecid—Leukopenia—Tolazamide—type 2 diabetes mellitus	0.000234	0.00718	CcSEcCtD
Probenecid—ABCC6—kidney—type 2 diabetes mellitus	0.000231	0.0147	CbGeAlD
Probenecid—SLC16A7—cardiovascular system—type 2 diabetes mellitus	0.000229	0.0146	CbGeAlD
Probenecid—Erythema multiforme—Repaglinide—type 2 diabetes mellitus	0.000228	0.00699	CcSEcCtD
Probenecid—Haemolytic anaemia—Gliclazide—type 2 diabetes mellitus	0.000221	0.00676	CcSEcCtD
Probenecid—SLC16A7—cortex of kidney—type 2 diabetes mellitus	0.000218	0.0139	CbGeAlD
Probenecid—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.000218	0.0139	CbGeAlD
Probenecid—Erythema multiforme—Rosiglitazone—type 2 diabetes mellitus	0.000216	0.0066	CcSEcCtD
Probenecid—Pollakiuria—Glimepiride—type 2 diabetes mellitus	0.000215	0.00658	CcSEcCtD
Probenecid—Alopecia—Repaglinide—type 2 diabetes mellitus	0.000213	0.00653	CcSEcCtD
Probenecid—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000211	0.00648	CcSEcCtD
Probenecid—SLC10A1—kidney—type 2 diabetes mellitus	0.00021	0.0133	CbGeAlD
Probenecid—ABCC6—adipose tissue—type 2 diabetes mellitus	0.000208	0.0132	CbGeAlD
Probenecid—Chlorpropamide—KCNJ11—type 2 diabetes mellitus	0.000207	0.175	CrCbGaD
Probenecid—Stevens-Johnson syndrome—Glimepiride—type 2 diabetes mellitus	0.000206	0.0063	CcSEcCtD
Probenecid—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000205	0.0131	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Sitagliptin—type 2 diabetes mellitus	0.000205	0.00628	CcSEcCtD
Probenecid—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.000204	0.00624	CcSEcCtD
Probenecid—Aplastic anaemia—Irbesartan—type 2 diabetes mellitus	0.000204	0.00624	CcSEcCtD
Probenecid—Haematuria—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00622	CcSEcCtD
Probenecid—SLC16A7—adipose tissue—type 2 diabetes mellitus	0.000202	0.0129	CbGeAlD
Probenecid—Tolbutamide—KCNJ11—type 2 diabetes mellitus	0.000202	0.171	CrCbGaD
Probenecid—SLCO1C1—kidney—type 2 diabetes mellitus	0.000197	0.0125	CbGeAlD
Probenecid—Pollakiuria—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00594	CcSEcCtD
Probenecid—Procainamide—DNMT1—type 2 diabetes mellitus	0.000192	0.162	CrCbGaD
Probenecid—Aplastic anaemia—Losartan—type 2 diabetes mellitus	0.000192	0.00587	CcSEcCtD
Probenecid—SLC22A11—kidney—type 2 diabetes mellitus	0.000191	0.0122	CbGeAlD
Probenecid—ABCC5—retina—type 2 diabetes mellitus	0.00019	0.0121	CbGeAlD
Probenecid—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000189	0.012	CbGeAlD
Probenecid—Leukopenia—Repaglinide—type 2 diabetes mellitus	0.000188	0.00576	CcSEcCtD
Probenecid—SLC22A7—kidney—type 2 diabetes mellitus	0.000187	0.0119	CbGeAlD
Probenecid—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.000187	0.00572	CcSEcCtD
Probenecid—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.000186	0.0119	CbGeAlD
Probenecid—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.000186	0.00569	CcSEcCtD
Probenecid—Flushing—Glipizide—type 2 diabetes mellitus	0.000185	0.00567	CcSEcCtD
Probenecid—Anaemia—Rosiglitazone—type 2 diabetes mellitus	0.000183	0.00562	CcSEcCtD
Probenecid—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.000182	0.0116	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Gliclazide—type 2 diabetes mellitus	0.00018	0.0055	CcSEcCtD
Probenecid—ABCC5—nephron tubule—type 2 diabetes mellitus	0.000179	0.0114	CbGeAlD
Probenecid—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	0.000178	0.00544	CcSEcCtD
Probenecid—SLCO1C1—adipose tissue—type 2 diabetes mellitus	0.000178	0.0113	CbGeAlD
Probenecid—Erythema multiforme—Glimepiride—type 2 diabetes mellitus	0.000176	0.00539	CcSEcCtD
Probenecid—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000176	0.0112	CbGeAlD
Probenecid—Erythema multiforme—Sitagliptin—type 2 diabetes mellitus	0.000176	0.00538	CcSEcCtD
Probenecid—Haemolytic anaemia—Irbesartan—type 2 diabetes mellitus	0.000174	0.00534	CcSEcCtD
Probenecid—SLC16A1—retina—type 2 diabetes mellitus	0.000173	0.011	CbGeAlD
Probenecid—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000171	0.00525	CcSEcCtD
Probenecid—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00017	0.0052	CcSEcCtD
Probenecid—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00017	0.0052	CcSEcCtD
Probenecid—Urticaria—Linagliptin—type 2 diabetes mellitus	0.000168	0.00515	CcSEcCtD
Probenecid—SLC22A2—kidney—type 2 diabetes mellitus	0.000166	0.0106	CbGeAlD
Probenecid—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000166	0.00509	CcSEcCtD
Probenecid—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000165	0.00504	CcSEcCtD
Probenecid—Haemolytic anaemia—Losartan—type 2 diabetes mellitus	0.000164	0.00503	CcSEcCtD
Probenecid—Urticaria—Acarbose—type 2 diabetes mellitus	0.000163	0.005	CcSEcCtD
Probenecid—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000162	0.00496	CcSEcCtD
Probenecid—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000162	0.0103	CbGeAlD
Probenecid—Urticaria—Nateglinide—type 2 diabetes mellitus	0.000157	0.00482	CcSEcCtD
Probenecid—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000156	0.00477	CcSEcCtD
Probenecid—Leukopenia—Glipizide—type 2 diabetes mellitus	0.000155	0.00476	CcSEcCtD
Probenecid—Nausea—Miglitol—type 2 diabetes mellitus	0.000155	0.00475	CcSEcCtD
Probenecid—Anaemia—Pioglitazone—type 2 diabetes mellitus	0.000154	0.00471	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Gliclazide—type 2 diabetes mellitus	0.000152	0.00467	CcSEcCtD
Probenecid—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000151	0.00463	CcSEcCtD
Probenecid—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000151	0.00463	CcSEcCtD
Probenecid—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000151	0.00463	CcSEcCtD
Probenecid—Anaemia—Glimepiride—type 2 diabetes mellitus	0.00015	0.00459	CcSEcCtD
Probenecid—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00455	CcSEcCtD
Probenecid—Headache—Tolbutamide—type 2 diabetes mellitus	0.000147	0.00451	CcSEcCtD
Probenecid—ABCC6—liver—type 2 diabetes mellitus	0.000146	0.00929	CbGeAlD
Probenecid—SLC16A1—cardiovascular system—type 2 diabetes mellitus	0.000146	0.00929	CbGeAlD
Probenecid—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000146	0.00447	CcSEcCtD
Probenecid—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000145	0.00445	CcSEcCtD
Probenecid—SLC16A1—kidney—type 2 diabetes mellitus	0.000143	0.00909	CbGeAlD
Probenecid—SLC16A7—liver—type 2 diabetes mellitus	0.000142	0.00902	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Irbesartan—type 2 diabetes mellitus	0.000142	0.00434	CcSEcCtD
Probenecid—ABCC5—adipose tissue—type 2 diabetes mellitus	0.000141	0.009	CbGeAlD
Probenecid—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000141	0.00433	CcSEcCtD
Probenecid—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000141	0.00433	CcSEcCtD
Probenecid—Haemolytic anaemia—Ramipril—type 2 diabetes mellitus	0.000141	0.00431	CcSEcCtD
Probenecid—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00014	0.00429	CcSEcCtD
Probenecid—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00014	0.00427	CcSEcCtD
Probenecid—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000136	0.00417	CcSEcCtD
Probenecid—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000136	0.00416	CcSEcCtD
Probenecid—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000136	0.00416	CcSEcCtD
Probenecid—Alopecia—Glyburide—type 2 diabetes mellitus	0.000136	0.00416	CcSEcCtD
Probenecid—Anorexia—Glipizide—type 2 diabetes mellitus	0.000135	0.00414	CcSEcCtD
Probenecid—Headache—Tolazamide—type 2 diabetes mellitus	0.000134	0.0041	CcSEcCtD
Probenecid—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000134	0.0041	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.000133	0.00409	CcSEcCtD
Probenecid—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000133	0.00408	CcSEcCtD
Probenecid—Headache—Linagliptin—type 2 diabetes mellitus	0.000132	0.00406	CcSEcCtD
Probenecid—SLC10A1—liver—type 2 diabetes mellitus	0.000132	0.00843	CbGeAlD
Probenecid—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000132	0.00405	CcSEcCtD
Probenecid—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000132	0.00404	CcSEcCtD
Probenecid—ABCC3—kidney—type 2 diabetes mellitus	0.000132	0.00839	CbGeAlD
Probenecid—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000131	0.00401	CcSEcCtD
Probenecid—Vomiting—Acarbose—type 2 diabetes mellitus	0.000131	0.004	CcSEcCtD
Probenecid—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.00013	0.00399	CcSEcCtD
Probenecid—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000129	0.00396	CcSEcCtD
Probenecid—SLC16A1—adipose tissue—type 2 diabetes mellitus	0.000129	0.00819	CbGeAlD
Probenecid—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000129	0.00394	CcSEcCtD
Probenecid—Flushing—Gliclazide—type 2 diabetes mellitus	0.000128	0.00392	CcSEcCtD
Probenecid—Nausea—Tolazamide—type 2 diabetes mellitus	0.000127	0.00389	CcSEcCtD
Probenecid—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000127	0.00389	CcSEcCtD
Probenecid—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000126	0.00387	CcSEcCtD
Probenecid—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000126	0.00386	CcSEcCtD
Probenecid—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000126	0.00386	CcSEcCtD
Probenecid—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000125	0.00382	CcSEcCtD
Probenecid—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000124	0.00788	CbGeAlD
Probenecid—Anaemia—Glyburide—type 2 diabetes mellitus	0.000124	0.00379	CcSEcCtD
Probenecid—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000123	0.00378	CcSEcCtD
Probenecid—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000123	0.00782	CbGeAlD
Probenecid—Nausea—Acarbose—type 2 diabetes mellitus	0.000122	0.00374	CcSEcCtD
Probenecid—Pain—Glipizide—type 2 diabetes mellitus	0.000121	0.00371	CcSEcCtD
Probenecid—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000121	0.00371	CcSEcCtD
Probenecid—SLC22A11—liver—type 2 diabetes mellitus	0.000121	0.0077	CbGeAlD
Probenecid—ABCC2—nephron tubule—type 2 diabetes mellitus	0.00012	0.00763	CbGeAlD
Probenecid—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00012	0.00367	CcSEcCtD
Probenecid—ABCC3—adipose tissue—type 2 diabetes mellitus	0.000119	0.00756	CbGeAlD
Probenecid—Pollakiuria—Losartan—type 2 diabetes mellitus	0.000118	0.00362	CcSEcCtD
Probenecid—SLC22A7—liver—type 2 diabetes mellitus	0.000118	0.00751	CbGeAlD
Probenecid—Nausea—Nateglinide—type 2 diabetes mellitus	0.000118	0.0036	CcSEcCtD
Probenecid—SLC22A1—kidney—type 2 diabetes mellitus	0.000117	0.00747	CbGeAlD
Probenecid—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000115	0.00352	CcSEcCtD
Probenecid—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00351	CcSEcCtD
Probenecid—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000115	0.00351	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000114	0.0035	CcSEcCtD
Probenecid—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000114	0.00349	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000113	0.00347	CcSEcCtD
Probenecid—SLCO1A2—kidney—type 2 diabetes mellitus	0.000113	0.00719	CbGeAlD
Probenecid—Pain—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00346	CcSEcCtD
Probenecid—Urticaria—Glipizide—type 2 diabetes mellitus	0.000113	0.00345	CcSEcCtD
Probenecid—Alopecia—Valsartan—type 2 diabetes mellitus	0.000112	0.00343	CcSEcCtD
Probenecid—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000111	0.0034	CcSEcCtD
Probenecid—Alopecia—Orlistat—type 2 diabetes mellitus	0.000111	0.00339	CcSEcCtD
Probenecid—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000109	0.00334	CcSEcCtD
Probenecid—ABCC4—kidney—type 2 diabetes mellitus	0.000109	0.00692	CbGeAlD
Probenecid—ABCC4—pancreas—type 2 diabetes mellitus	0.000108	0.00688	CbGeAlD
Probenecid—SLC22A8—kidney—type 2 diabetes mellitus	0.000108	0.00687	CbGeAlD
Probenecid—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000108	0.00331	CcSEcCtD
Probenecid—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000108	0.00331	CcSEcCtD
Probenecid—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000107	0.00329	CcSEcCtD
Probenecid—Headache—Repaglinide—type 2 diabetes mellitus	0.000107	0.00329	CcSEcCtD
Probenecid—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000107	0.00328	CcSEcCtD
Probenecid—Flushing—Metformin—type 2 diabetes mellitus	0.000107	0.00328	CcSEcCtD
Probenecid—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000106	0.00674	CbGeAlD
Probenecid—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000106	0.00673	CbGeAlD
Probenecid—ABCC2—kidney—type 2 diabetes mellitus	0.000105	0.0067	CbGeAlD
Probenecid—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000105	0.00669	CbGeAlD
Probenecid—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000105	0.00322	CcSEcCtD
Probenecid—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000105	0.00321	CcSEcCtD
Probenecid—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000104	0.0032	CcSEcCtD
Probenecid—Anorexia—Glyburide—type 2 diabetes mellitus	0.000104	0.00319	CcSEcCtD
Probenecid—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00318	CcSEcCtD
Probenecid—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000103	0.00653	CbGeAlD
Probenecid—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000102	0.00313	CcSEcCtD
Probenecid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000102	0.00312	CcSEcCtD
Probenecid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000101	0.00311	CcSEcCtD
Probenecid—Flushing—Irbesartan—type 2 diabetes mellitus	0.000101	0.0031	CcSEcCtD
Probenecid—Pruritus—Glipizide—type 2 diabetes mellitus	0.0001	0.00307	CcSEcCtD
Probenecid—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0001	0.00307	CcSEcCtD
Probenecid—ABCC5—liver—type 2 diabetes mellitus	9.92e-05	0.00631	CbGeAlD
Probenecid—SLC22A5—retina—type 2 diabetes mellitus	9.86e-05	0.00627	CbGeAlD
Probenecid—ABCC4—adipose tissue—type 2 diabetes mellitus	9.81e-05	0.00624	CbGeAlD
Probenecid—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	9.75e-05	0.00299	CcSEcCtD
Probenecid—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	9.72e-05	0.00298	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	9.7e-05	0.00297	CcSEcCtD
Probenecid—Erythema multiforme—Losartan—type 2 diabetes mellitus	9.69e-05	0.00297	CcSEcCtD
Probenecid—Nausea—Rosiglitazone—type 2 diabetes mellitus	9.62e-05	0.00295	CcSEcCtD
Probenecid—Flushing—Losartan—type 2 diabetes mellitus	9.51e-05	0.00291	CcSEcCtD
Probenecid—Decreased appetite—Glyburide—type 2 diabetes mellitus	9.48e-05	0.00291	CcSEcCtD
Probenecid—Urticaria—Bromocriptine—type 2 diabetes mellitus	9.48e-05	0.0029	CcSEcCtD
Probenecid—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	9.44e-05	0.00289	CcSEcCtD
Probenecid—Dizziness—Glipizide—type 2 diabetes mellitus	9.38e-05	0.00287	CcSEcCtD
Probenecid—Pruritus—Glimepiride—type 2 diabetes mellitus	9.36e-05	0.00287	CcSEcCtD
Probenecid—SLC22A5—nephron tubule—type 2 diabetes mellitus	9.28e-05	0.00591	CbGeAlD
Probenecid—Alopecia—Losartan—type 2 diabetes mellitus	9.05e-05	0.00277	CcSEcCtD
Probenecid—ABCC1—cortex of kidney—type 2 diabetes mellitus	9.04e-05	0.00575	CbGeAlD
Probenecid—SLC16A1—liver—type 2 diabetes mellitus	9.03e-05	0.00574	CbGeAlD
Probenecid—Vomiting—Glipizide—type 2 diabetes mellitus	9.01e-05	0.00276	CcSEcCtD
Probenecid—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	9e-05	0.00276	CcSEcCtD
Probenecid—Dizziness—Pioglitazone—type 2 diabetes mellitus	8.98e-05	0.00275	CcSEcCtD
Probenecid—Dermatitis—Glipizide—type 2 diabetes mellitus	8.93e-05	0.00274	CcSEcCtD
Probenecid—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	8.89e-05	0.00272	CcSEcCtD
Probenecid—Headache—Glipizide—type 2 diabetes mellitus	8.88e-05	0.00272	CcSEcCtD
Probenecid—Anaemia—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.00268	CcSEcCtD
Probenecid—Dizziness—Glimepiride—type 2 diabetes mellitus	8.75e-05	0.00268	CcSEcCtD
Probenecid—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.72e-05	0.00267	CcSEcCtD
Probenecid—Urticaria—Glyburide—type 2 diabetes mellitus	8.67e-05	0.00266	CcSEcCtD
Probenecid—Anorexia—Valsartan—type 2 diabetes mellitus	8.58e-05	0.00263	CcSEcCtD
Probenecid—Headache—Pioglitazone—type 2 diabetes mellitus	8.51e-05	0.00261	CcSEcCtD
Probenecid—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.0026	CcSEcCtD
Probenecid—Nausea—Glipizide—type 2 diabetes mellitus	8.42e-05	0.00258	CcSEcCtD
Probenecid—Vomiting—Glimepiride—type 2 diabetes mellitus	8.41e-05	0.00258	CcSEcCtD
Probenecid—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.39e-05	0.00257	CcSEcCtD
Probenecid—Pain—Gliclazide—type 2 diabetes mellitus	8.38e-05	0.00257	CcSEcCtD
Probenecid—ABCC1—adipose tissue—type 2 diabetes mellitus	8.36e-05	0.00532	CbGeAlD
Probenecid—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.33e-05	0.00255	CcSEcCtD
Probenecid—ABCC3—liver—type 2 diabetes mellitus	8.33e-05	0.0053	CbGeAlD
Probenecid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.31e-05	0.00255	CcSEcCtD
Probenecid—Erythema multiforme—Ramipril—type 2 diabetes mellitus	8.31e-05	0.00255	CcSEcCtD
Probenecid—Headache—Glimepiride—type 2 diabetes mellitus	8.29e-05	0.00254	CcSEcCtD
Probenecid—Headache—Sitagliptin—type 2 diabetes mellitus	8.26e-05	0.00253	CcSEcCtD
Probenecid—Anaemia—Losartan—type 2 diabetes mellitus	8.24e-05	0.00253	CcSEcCtD
Probenecid—SLC22A5—kidney—type 2 diabetes mellitus	8.16e-05	0.00519	CbGeAlD
Probenecid—Flushing—Ramipril—type 2 diabetes mellitus	8.15e-05	0.0025	CcSEcCtD
Probenecid—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.04e-05	0.00246	CcSEcCtD
Probenecid—Leukopenia—Losartan—type 2 diabetes mellitus	7.98e-05	0.00245	CcSEcCtD
Probenecid—SLC22A5—cortex of kidney—type 2 diabetes mellitus	7.95e-05	0.00506	CbGeAlD
Probenecid—CYP2C8—kidney—type 2 diabetes mellitus	7.9e-05	0.00503	CbGeAlD
Probenecid—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.89e-05	0.00242	CcSEcCtD
Probenecid—Nausea—Glimepiride—type 2 diabetes mellitus	7.86e-05	0.00241	CcSEcCtD
Probenecid—Nausea—Sitagliptin—type 2 diabetes mellitus	7.83e-05	0.0024	CcSEcCtD
Probenecid—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.82e-05	0.0024	CcSEcCtD
Probenecid—Anorexia—Metformin—type 2 diabetes mellitus	7.81e-05	0.00239	CcSEcCtD
Probenecid—Urticaria—Gliclazide—type 2 diabetes mellitus	7.78e-05	0.00238	CcSEcCtD
Probenecid—Alopecia—Ramipril—type 2 diabetes mellitus	7.76e-05	0.00238	CcSEcCtD
Probenecid—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.75e-05	0.00237	CcSEcCtD
Probenecid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.00237	CcSEcCtD
Probenecid—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.73e-05	0.00237	CcSEcCtD
Probenecid—Pruritus—Glyburide—type 2 diabetes mellitus	7.72e-05	0.00236	CcSEcCtD
Probenecid—Pain—Orlistat—type 2 diabetes mellitus	7.61e-05	0.00233	CcSEcCtD
Probenecid—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.59e-05	0.00232	CcSEcCtD
Probenecid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.52e-05	0.0023	CcSEcCtD
Probenecid—Headache—Bromocriptine—type 2 diabetes mellitus	7.48e-05	0.00229	CcSEcCtD
Probenecid—SLC22A1—liver—type 2 diabetes mellitus	7.42e-05	0.00472	CbGeAlD
Probenecid—Anorexia—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.00226	CcSEcCtD
Probenecid—SLC22A5—adipose tissue—type 2 diabetes mellitus	7.35e-05	0.00468	CbGeAlD
Probenecid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.28e-05	0.00223	CcSEcCtD
Probenecid—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.22e-05	0.00221	CcSEcCtD
Probenecid—CYP2C9—cardiovascular system—type 2 diabetes mellitus	7.17e-05	0.00456	CbGeAlD
Probenecid—Urticaria—Valsartan—type 2 diabetes mellitus	7.15e-05	0.00219	CcSEcCtD
Probenecid—SLCO1A2—liver—type 2 diabetes mellitus	7.15e-05	0.00455	CbGeAlD
Probenecid—Decreased appetite—Metformin—type 2 diabetes mellitus	7.13e-05	0.00218	CcSEcCtD
Probenecid—ALB—liver—type 2 diabetes mellitus	7.1e-05	0.00452	CbGeAlD
Probenecid—Nausea—Bromocriptine—type 2 diabetes mellitus	7.09e-05	0.00217	CcSEcCtD
Probenecid—Urticaria—Orlistat—type 2 diabetes mellitus	7.07e-05	0.00216	CcSEcCtD
Probenecid—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.03e-05	0.00215	CcSEcCtD
Probenecid—Anorexia—Losartan—type 2 diabetes mellitus	6.94e-05	0.00213	CcSEcCtD
Probenecid—Vomiting—Glyburide—type 2 diabetes mellitus	6.94e-05	0.00213	CcSEcCtD
Probenecid—Pruritus—Gliclazide—type 2 diabetes mellitus	6.93e-05	0.00212	CcSEcCtD
Probenecid—ABCC4—liver—type 2 diabetes mellitus	6.88e-05	0.00438	CbGeAlD
Probenecid—Dermatitis—Glyburide—type 2 diabetes mellitus	6.87e-05	0.00211	CcSEcCtD
Probenecid—Leukopenia—Ramipril—type 2 diabetes mellitus	6.85e-05	0.0021	CcSEcCtD
Probenecid—Headache—Glyburide—type 2 diabetes mellitus	6.84e-05	0.00209	CcSEcCtD
Probenecid—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.00206	CcSEcCtD
Probenecid—ABCC2—liver—type 2 diabetes mellitus	6.66e-05	0.00424	CbGeAlD
Probenecid—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.63e-05	0.00203	CcSEcCtD
Probenecid—Pain—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.00203	CcSEcCtD
Probenecid—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.55e-05	0.00201	CcSEcCtD
Probenecid—Urticaria—Metformin—type 2 diabetes mellitus	6.51e-05	0.002	CcSEcCtD
Probenecid—Nausea—Glyburide—type 2 diabetes mellitus	6.48e-05	0.00199	CcSEcCtD
Probenecid—Dizziness—Gliclazide—type 2 diabetes mellitus	6.48e-05	0.00198	CcSEcCtD
Probenecid—Pruritus—Valsartan—type 2 diabetes mellitus	6.37e-05	0.00195	CcSEcCtD
Probenecid—Decreased appetite—Losartan—type 2 diabetes mellitus	6.33e-05	0.00194	CcSEcCtD
Probenecid—Pruritus—Orlistat—type 2 diabetes mellitus	6.29e-05	0.00193	CcSEcCtD
Probenecid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.24e-05	0.00191	CcSEcCtD
Probenecid—Vomiting—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.00191	CcSEcCtD
Probenecid—Pain—Losartan—type 2 diabetes mellitus	6.23e-05	0.00191	CcSEcCtD
Probenecid—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.17e-05	0.00189	CcSEcCtD
Probenecid—Urticaria—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.00188	CcSEcCtD
Probenecid—Headache—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.00188	CcSEcCtD
Probenecid—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.00187	CcSEcCtD
Probenecid—Dizziness—Valsartan—type 2 diabetes mellitus	5.95e-05	0.00182	CcSEcCtD
Probenecid—Anorexia—Ramipril—type 2 diabetes mellitus	5.95e-05	0.00182	CcSEcCtD
Probenecid—Dizziness—Orlistat—type 2 diabetes mellitus	5.88e-05	0.0018	CcSEcCtD
Probenecid—ABCC1—liver—type 2 diabetes mellitus	5.86e-05	0.00373	CbGeAlD
Probenecid—Nausea—Gliclazide—type 2 diabetes mellitus	5.82e-05	0.00178	CcSEcCtD
Probenecid—Pruritus—Metformin—type 2 diabetes mellitus	5.8e-05	0.00178	CcSEcCtD
Probenecid—Urticaria—Losartan—type 2 diabetes mellitus	5.78e-05	0.00177	CcSEcCtD
Probenecid—Body temperature increased—Losartan—type 2 diabetes mellitus	5.76e-05	0.00176	CcSEcCtD
Probenecid—Vomiting—Valsartan—type 2 diabetes mellitus	5.72e-05	0.00175	CcSEcCtD
Probenecid—CYP2C19—liver—type 2 diabetes mellitus	5.72e-05	0.00364	CbGeAlD
Probenecid—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.00175	CcSEcCtD
Probenecid—Dermatitis—Valsartan—type 2 diabetes mellitus	5.67e-05	0.00174	CcSEcCtD
Probenecid—Vomiting—Orlistat—type 2 diabetes mellitus	5.66e-05	0.00173	CcSEcCtD
Probenecid—Headache—Valsartan—type 2 diabetes mellitus	5.64e-05	0.00173	CcSEcCtD
Probenecid—Dermatitis—Orlistat—type 2 diabetes mellitus	5.6e-05	0.00172	CcSEcCtD
Probenecid—Headache—Orlistat—type 2 diabetes mellitus	5.57e-05	0.00171	CcSEcCtD
Probenecid—Pruritus—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.00168	CcSEcCtD
Probenecid—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.43e-05	0.00166	CcSEcCtD
Probenecid—Dizziness—Metformin—type 2 diabetes mellitus	5.42e-05	0.00166	CcSEcCtD
Probenecid—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.36e-05	0.00164	CcSEcCtD
Probenecid—ABCB1—islet of Langerhans—type 2 diabetes mellitus	5.35e-05	0.00341	CbGeAlD
Probenecid—CYP3A4—kidney—type 2 diabetes mellitus	5.35e-05	0.0034	CbGeAlD
Probenecid—Nausea—Valsartan—type 2 diabetes mellitus	5.35e-05	0.00164	CcSEcCtD
Probenecid—Nausea—Orlistat—type 2 diabetes mellitus	5.28e-05	0.00162	CcSEcCtD
Probenecid—Vomiting—Metformin—type 2 diabetes mellitus	5.21e-05	0.0016	CcSEcCtD
Probenecid—Dermatitis—Metformin—type 2 diabetes mellitus	5.16e-05	0.00158	CcSEcCtD
Probenecid—SLC22A5—liver—type 2 diabetes mellitus	5.16e-05	0.00328	CbGeAlD
Probenecid—Pruritus—Losartan—type 2 diabetes mellitus	5.15e-05	0.00158	CcSEcCtD
Probenecid—Headache—Metformin—type 2 diabetes mellitus	5.14e-05	0.00157	CcSEcCtD
Probenecid—Dizziness—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.00157	CcSEcCtD
Probenecid—CYP2C8—liver—type 2 diabetes mellitus	4.99e-05	0.00318	CbGeAlD
Probenecid—Urticaria—Ramipril—type 2 diabetes mellitus	4.96e-05	0.00152	CcSEcCtD
Probenecid—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.93e-05	0.00151	CcSEcCtD
Probenecid—Vomiting—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.00151	CcSEcCtD
Probenecid—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.00149	CcSEcCtD
Probenecid—Nausea—Metformin—type 2 diabetes mellitus	4.87e-05	0.00149	CcSEcCtD
Probenecid—Headache—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.00148	CcSEcCtD
Probenecid—Dizziness—Losartan—type 2 diabetes mellitus	4.81e-05	0.00147	CcSEcCtD
Probenecid—Vomiting—Losartan—type 2 diabetes mellitus	4.63e-05	0.00142	CcSEcCtD
Probenecid—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.6e-05	0.00141	CcSEcCtD
Probenecid—Nausea—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.00141	CcSEcCtD
Probenecid—Dermatitis—Losartan—type 2 diabetes mellitus	4.59e-05	0.0014	CcSEcCtD
Probenecid—ABCB1—retina—type 2 diabetes mellitus	4.58e-05	0.00291	CbGeAlD
Probenecid—Headache—Losartan—type 2 diabetes mellitus	4.56e-05	0.0014	CcSEcCtD
Probenecid—CYP2C9—liver—type 2 diabetes mellitus	4.43e-05	0.00282	CbGeAlD
Probenecid—Pruritus—Ramipril—type 2 diabetes mellitus	4.42e-05	0.00135	CcSEcCtD
Probenecid—Nausea—Losartan—type 2 diabetes mellitus	4.32e-05	0.00132	CcSEcCtD
Probenecid—ABCB1—nephron tubule—type 2 diabetes mellitus	4.31e-05	0.00274	CbGeAlD
Probenecid—Dizziness—Ramipril—type 2 diabetes mellitus	4.13e-05	0.00126	CcSEcCtD
Probenecid—Vomiting—Ramipril—type 2 diabetes mellitus	3.97e-05	0.00122	CcSEcCtD
Probenecid—Dermatitis—Ramipril—type 2 diabetes mellitus	3.93e-05	0.0012	CcSEcCtD
Probenecid—Headache—Ramipril—type 2 diabetes mellitus	3.91e-05	0.0012	CcSEcCtD
Probenecid—ABCB1—cardiovascular system—type 2 diabetes mellitus	3.87e-05	0.00246	CbGeAlD
Probenecid—ABCB1—kidney—type 2 diabetes mellitus	3.79e-05	0.00241	CbGeAlD
Probenecid—ABCB1—pancreas—type 2 diabetes mellitus	3.76e-05	0.00239	CbGeAlD
Probenecid—Nausea—Ramipril—type 2 diabetes mellitus	3.71e-05	0.00114	CcSEcCtD
Probenecid—ABCB1—cortex of kidney—type 2 diabetes mellitus	3.69e-05	0.00235	CbGeAlD
Probenecid—ABCB1—adipose tissue—type 2 diabetes mellitus	3.41e-05	0.00217	CbGeAlD
Probenecid—CYP3A4—liver—type 2 diabetes mellitus	3.38e-05	0.00215	CbGeAlD
Probenecid—ABCB1—liver—type 2 diabetes mellitus	2.39e-05	0.00152	CbGeAlD
Probenecid—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	8.38e-07	2.34e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	8.36e-07	2.34e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GCG—type 2 diabetes mellitus	8.33e-07	2.33e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	8.33e-07	2.33e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	8.27e-07	2.31e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	8.26e-07	2.31e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	8.26e-07	2.31e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	8.22e-07	2.3e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	8.21e-07	2.29e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	8.19e-07	2.29e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	8.19e-07	2.29e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	8.1e-07	2.26e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.05e-07	2.25e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.03e-07	2.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.01e-07	2.24e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	7.9e-07	2.21e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	7.89e-07	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.89e-07	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	7.86e-07	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	7.86e-07	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	7.86e-07	2.2e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—type 2 diabetes mellitus	7.85e-07	2.19e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	7.8e-07	2.18e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	7.8e-07	2.18e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—type 2 diabetes mellitus	7.79e-07	2.18e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	7.72e-07	2.16e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.7e-07	2.15e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.68e-07	2.15e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	7.65e-07	2.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	7.65e-07	2.14e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.61e-07	2.13e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.61e-07	2.13e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	7.61e-07	2.13e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.57e-07	2.11e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.56e-07	2.11e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	7.56e-07	2.11e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.54e-07	2.11e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.54e-07	2.11e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	7.51e-07	2.1e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SRC—type 2 diabetes mellitus	7.49e-07	2.09e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	7.49e-07	2.09e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	7.48e-07	2.09e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	7.48e-07	2.09e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.42e-07	2.07e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	7.3e-07	2.04e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.3e-07	2.04e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	7.29e-07	2.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.28e-07	2.03e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.28e-07	2.03e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.28e-07	2.03e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.28e-07	2.03e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	7.22e-07	2.02e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.22e-07	2.02e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	7.19e-07	2.01e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	7.19e-07	2.01e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—type 2 diabetes mellitus	7.18e-07	2.01e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.18e-07	2.01e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GNB3—type 2 diabetes mellitus	7.18e-07	2.01e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	7.15e-07	2e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	7.13e-07	1.99e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	7.11e-07	1.99e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	7.11e-07	1.99e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	7.09e-07	1.98e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAT—type 2 diabetes mellitus	7.05e-07	1.97e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	7e-07	1.96e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.98e-07	1.95e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	6.94e-07	1.94e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	6.91e-07	1.93e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.9e-07	1.93e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	6.88e-07	1.92e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	6.88e-07	1.92e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOB—type 2 diabetes mellitus	6.85e-07	1.91e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	6.82e-07	1.91e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	6.82e-07	1.91e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	6.7e-07	1.87e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	6.69e-07	1.87e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—SRC—type 2 diabetes mellitus	6.68e-07	1.87e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	6.66e-07	1.86e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.58e-07	1.84e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	6.58e-07	1.84e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	6.57e-07	1.84e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—LPL—type 2 diabetes mellitus	6.54e-07	1.83e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.49e-07	1.81e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	6.44e-07	1.8e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.44e-07	1.8e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	6.44e-07	1.8e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	6.42e-07	1.79e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	6.41e-07	1.79e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	6.41e-07	1.79e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	6.4e-07	1.79e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GPX1—type 2 diabetes mellitus	6.38e-07	1.78e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	6.33e-07	1.77e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.29e-07	1.76e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.29e-07	1.76e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.26e-07	1.75e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	6.25e-07	1.75e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CD36—type 2 diabetes mellitus	6.21e-07	1.74e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.18e-07	1.73e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	6.17e-07	1.72e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	6.15e-07	1.72e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	6.14e-07	1.71e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.14e-07	1.71e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	6.13e-07	1.71e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.06e-07	1.69e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	6.02e-07	1.68e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—type 2 diabetes mellitus	6.02e-07	1.68e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6e-07	1.68e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	5.98e-07	1.67e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	5.97e-07	1.67e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.93e-07	1.66e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.93e-07	1.66e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	5.92e-07	1.65e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	5.89e-07	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.88e-07	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.88e-07	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	5.87e-07	1.64e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—type 2 diabetes mellitus	5.85e-07	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.85e-07	1.63e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.83e-07	1.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.82e-07	1.63e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	5.81e-07	1.62e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.78e-07	1.62e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.78e-07	1.62e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.78e-07	1.62e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARA—type 2 diabetes mellitus	5.77e-07	1.61e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	5.77e-07	1.61e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.75e-07	1.61e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	5.74e-07	1.61e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.73e-07	1.6e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	5.72e-07	1.6e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.64e-07	1.58e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	5.62e-07	1.57e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	5.61e-07	1.57e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.61e-07	1.57e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	5.6e-07	1.57e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—type 2 diabetes mellitus	5.59e-07	1.56e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AGT—type 2 diabetes mellitus	5.59e-07	1.56e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.59e-07	1.56e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.58e-07	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	5.58e-07	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	5.53e-07	1.55e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	5.51e-07	1.54e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	5.51e-07	1.54e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CALM1—type 2 diabetes mellitus	5.5e-07	1.54e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOE—type 2 diabetes mellitus	5.48e-07	1.53e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	5.45e-07	1.52e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	5.45e-07	1.52e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.44e-07	1.52e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOA1—type 2 diabetes mellitus	5.42e-07	1.51e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.37e-07	1.5e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	5.35e-07	1.5e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	5.28e-07	1.48e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	5.24e-07	1.46e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	5.22e-07	1.46e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.19e-07	1.45e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.19e-07	1.45e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.19e-07	1.45e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	5.18e-07	1.45e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.16e-07	1.44e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.09e-07	1.42e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	5.08e-07	1.42e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.06e-07	1.41e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.04e-07	1.41e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	5.02e-07	1.4e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	5.02e-07	1.4e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.94e-07	1.38e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4.94e-07	1.38e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	4.92e-07	1.37e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.9e-07	1.37e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	4.86e-07	1.36e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.82e-07	1.35e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.82e-07	1.35e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.8e-07	1.34e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	4.8e-07	1.34e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARG—type 2 diabetes mellitus	4.77e-07	1.33e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.75e-07	1.33e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.74e-07	1.33e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.73e-07	1.32e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	4.71e-07	1.32e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.69e-07	1.31e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.69e-07	1.31e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—INS—type 2 diabetes mellitus	4.68e-07	1.31e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	4.65e-07	1.3e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.58e-07	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.5e-07	1.26e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—type 2 diabetes mellitus	4.5e-07	1.26e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.5e-07	1.26e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.5e-07	1.26e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.48e-07	1.25e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	4.43e-07	1.24e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.43e-07	1.24e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	4.32e-07	1.21e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.28e-07	1.2e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	4.2e-07	1.17e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.18e-07	1.17e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—type 2 diabetes mellitus	4.15e-07	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	4.13e-07	1.15e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	4.13e-07	1.15e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	4.1e-07	1.15e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—NOS3—type 2 diabetes mellitus	4.1e-07	1.15e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.1e-07	1.15e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-07	1.09e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.88e-07	1.08e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.88e-07	1.08e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.86e-07	1.08e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.86e-07	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.85e-07	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.83e-07	1.07e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.81e-07	1.06e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	3.78e-07	1.06e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.76e-07	1.05e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	3.75e-07	1.05e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.7e-07	1.03e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	3.68e-07	1.03e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	3.68e-07	1.03e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.6e-07	1.01e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.6e-07	1.01e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.59e-07	1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.53e-07	9.86e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.51e-07	9.82e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	3.47e-07	9.71e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.45e-07	9.65e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.44e-07	9.62e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.37e-07	9.42e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-07	9.39e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-07	9.39e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.35e-07	9.37e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.31e-07	9.25e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.29e-07	9.19e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.18e-07	8.88e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.12e-07	8.71e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3.07e-07	8.59e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	3.03e-07	8.46e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.02e-07	8.44e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.97e-07	8.3e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.96e-07	8.27e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.92e-07	8.17e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	2.82e-07	7.88e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.58e-07	7.2e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.53e-07	7.06e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.32e-07	6.47e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.22e-07	6.19e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.22e-07	6.19e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.03e-07	5.66e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.9e-07	5.3e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.89e-07	5.27e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.69e-07	4.73e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-07	4.62e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.54e-07	4.32e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-07	2.85e-06	CbGpPWpGaD
